Skip to content. | Skip to navigation

Personal tools
Log in
Sections
Home › News › RCS awarded new audit contracts by Healthcare Quality Improvement Partnership

RCS awarded new audit contracts by Healthcare Quality Improvement Partnership

23 October 2012

The Royal College of Surgeons’ Clinical Effectiveness Unit is delighted to have been awarded the contracts for a new National Prostate Cancer Audit and the National Vascular Registry by Healthcare Quality Improvement Partnership (HQIP).

Prostate cancer is the commonest solid cancer in men, with 40,000 new cases diagnosed per year in the UK. There are concerns about over-diagnosis and over-treatment in men with low risk disease, while men with locally advanced or high-risk disease may not be getting the radical treatments they need. The National Prostate Cancer Audit will assess patient outcomes, improve clinical practice and ultimately save lives.The audit will be undertaken by a team involving the British Association of Urological Surgeons (BAUS), the British Uro-Oncology Group and the National Cancer Intelligence Network, in partnership with the College.

The National Vascular Registry (NVR) aims to improve the quality of care for patients undergoing different vascular procedures. It will examine care related to the repair of Abdominal Aortic Aneurysms, carotid endarterectomy among stroke patients, and interventions for peripheral arterial disease. The Registry will be run in collaboration with the Vascular Society of Great Britain and Ireland (VSGBI).  It forms an essential element of their quality improvement programme and will build on the success of the National Vascular Database.

David Cromwell, Director of the Clinical Effectiveness Unit at the RCS, said:

“We are delighted to begin these two new projects. Both will help to deliver tangible improvements in patient care by providing clinicians with timely and detailed information on their practice.”

Adrian Joyce, President of BAUS, said:

“We strongly support this proposal for a national study to audit the management of men with a new diagnosis of prostate cancer and sincerely hope that it will improve clinical practice, patient outcomes and, ultimately, save lives. The success of this audit has the full support and commitment of our members.”

David Mitchell, Chair of the Audit and Quality Improvement Committee, The Vascular Society, said:

“The national vascular registry comes at an important time as vascular surgery becomes a new speciality. The registry will enable vascular specialists to gather information that will help to deliver improvements in care for our patients.”

Helen Laing, HQIP National Clinical Audit Lead, said:

“We are delighted to launch these projects in two vital areas of healthcare. In its tenders the teams at the Clinical Effectiveness Unit clearly illustrated strategies which will provide platforms for real change at local levels and we look forward to seeing the results.”